ArticleRadiation oncology (London, England)2009

The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells.

James W Welsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.